Medarex, Inc. (NASDAQ:MEDX.DL)
CAPS Rating:
A biopharmaceutical company developing therapeutic products for cancer, inflammation, autoimmune disorders and other life-threatening and debilitating diseases based on its proprietary technology.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked MEDX.DL yet. Tell us why you think MEDX.DL will outperform or underperform the market.
RSS Headlines
Fool UK
